Protonitazene Explained
Drug Name: | Protonitazene |
Legal Br: | F1 |
Legal Uk: | PSA |
Legal Us: | Schedule I |
Legal De: | Anlage II |
C: | 23 |
H: | 30 |
N: | 4 |
O: | 3 |
Iupac Name: | N,N-diethyl-2-[5-nitro-2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine |
Cas Number: | 95958-84-2 |
Pubchem: | 156589001 |
Unii: | 4A6RZQ7M2V |
Kegg: | C22683 |
Smiles: | CCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-] |
Stdinchi: | 1S/C23H30N4O3/c1-4-15-30-20-10-7-18(8-11-20)16-23-24-21-17-19(27(28)29)9-12-22(21)26(23)14-13-25(5-2)6-3/h7-12,17H,4-6,13-16H2,1-3H3 |
Stdinchikey: | SJHUJFHOXYDSJY-UHFFFAOYSA-N |
Protonitazene is a benzimidazole derivative with potent opioid effects which has been sold over the internet as a designer drug since 2019, and has been identified in various European countries, as well as Canada, the US and Australia.[1] It has been linked to numerous cases of drug overdose, and is a Schedule I drug in the US.[2] [3] [4] [5] [6]
It was developed by a Swiss pharmaceutical company in the 1950s as an alternative to morphine, but was never adopted due to severe side effects.[7]
See also
Notes and References
- Edinoff AN, Martinez Garza D, Vining SP, Vasterling ME, Jackson ED, Murnane KS, Kaye AM, Fair RN, Torres YJ, Badr AE, Cornett EM, Kaye AD . New Synthetic Opioids: Clinical Considerations and Dangers . Pain and Therapy . 12 . 2 . 399–421 . April 2023 . 36826742 . 9950705 . 10.1007/s40122-023-00481-6 .
- Schumann JL, Syrjanen R, Alford K, Mashetty S, Castle JW, Rotella J, Maplesden J, Greene SL . 6 . Intoxications in an Australian Emergency Department Involving 'Nitazene' Benzylbenzimidazole Synthetic Opioids (Etodesnitazene, Butonitazene and Protonitazene) . Journal of Analytical Toxicology . August 2022 . 47 . 1 . e6–e9 . 35983900 . 10.1093/jat/bkac062 .
- Kanamori T, Okada Y, Segawa H, Yamamuro T, Kuwayama K, Tsujikawa K, Iwata YT . Analysis of highly potent synthetic opioid nitazene analogs and their positional isomers . Drug Testing and Analysis . November 2022 . 15 . 4 . 449–457 . 36437623 . 10.1002/dta.3415 . 254042990 .
- Papsun DM, Krotulski AJ, Logan BK . Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances . The American Journal of Forensic Medicine and Pathology . 43 . 4 . 315–327 . December 2022 . 36103391 . 10.1097/PAF.0000000000000787 . 252220135 .
- Walton SE, Krotulski AJ, Logan BK . A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS) . Journal of Analytical Toxicology . 46 . 3 . 221–231 . March 2022 . 34792157 . 10.1093/jat/bkab117 . 8935987 .
- 21 CFR Part 1308. [Docket No. DEA–900] Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I. ]. Drug Enforcement Administration . Federal Register . 12 April 2022 . 87 . 70 . 21556 .
- Web site: Faugstad . Sebastian . 23 November 2022 . 20-åring døde etter inntak av nytt, livsfarlig rusmiddel . 20-year-old died after consuming a new, life-threatening drug . 26 July 2023 . . nb-NO . Protonitazen er et syntetisk opioid som ble utviklet av et sveitsisk legemiddelselskap på 50-tallet. Det var ment som et alternativ til morfin, men på grunn av alvorlige bivirkninger ble stoffet aldri tatt i bruk. . Protonitazen is a synthetic opioid that was developed by a Swiss pharmaceutical company in the 50s. It was intended as an alternative to morphine, but due to severe side effects, the drug was never used..